BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23990188)

  • 1. Systematic review and meta-analysis of chronic kidney disease as predictor of atrial fibrillation recurrence following catheter ablation.
    Li M; Liu T; Luo D; Li G
    Cardiol J; 2014; 21(1):89-95. PubMed ID: 23990188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired renal function is associated with recurrence after cryoballoon catheter ablation for paroxysmal atrial fibrillation: A potential effect of non-pulmonary vein foci.
    Yanagisawa S; Inden Y; Kato H; Fujii A; Mizutani Y; Ito T; Kamikubo Y; Kanzaki Y; Ando M; Hirai M; Shibata R; Murohara T
    J Cardiol; 2017 Jan; 69(1):3-10. PubMed ID: 27499270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.
    Deng H; Shantsila A; Xue Y; Bai Y; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Wu S; Lip GYH
    Arch Cardiovasc Dis; 2019; 112(6-7):420-429. PubMed ID: 31133543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up.
    Naruse Y; Tada H; Sekiguchi Y; Machino T; Ozawa M; Yamasaki H; Igarashi M; Kuroki K; Itoh Y; Murakoshi N; Yamaguchi I; Aonuma K
    Heart Rhythm; 2011 Mar; 8(3):335-41. PubMed ID: 21056121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation.
    Navaravong L; Barakat M; Burgon N; Mahnkopf C; Koopmann M; Ranjan R; Kholmovski E; Marrouche N; Akoum N
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):21-7. PubMed ID: 25142836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of Clinical Outcomes of Electrical Cardioversion and Catheter Ablation in Patients with Atrial Fibrillation and Chronic Kidney Disease.
    Diemberger I; Genovesi S; Massaro G; Reggiani MLB; Frisoni J; Gorlato G; Mauro E; Padeletti M; Vincenti A; Boriani G
    Curr Pharm Des; 2018; 24(24):2794-2801. PubMed ID: 30156153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter Ablation for Atrial Fibrillation in Patients with Chronic Kidney Disease and on Dialysis: A Meta-Analysis and Review.
    Chung I; Khan Y; Warrens H; Seshasai RK; Sohal M; Banerjee D
    Cardiorenal Med; 2022; 12(4):155-172. PubMed ID: 35820393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of chronic kidney disease on atrial fibrillation recurrence following radiofrequency and cryoballoon ablation: A meta-analysis.
    Lee WC; Wu PJ; Fang CY; Chen HC; Chen MC
    Int J Clin Pract; 2021 Oct; 75(10):e14173. PubMed ID: 33756030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Renal Dysfunction on Left Atrial Structural Remodeling and Recurrence After Catheter Ablation for Atrial Fibrillation - A Propensity Score Matching Analysis.
    Takahashi Y; Yamaguchi T; Fukui A; Otsubo T; Hirota K; Kawano Y; Nakashima K; Tahara M; Kitai T; Kawaguchi A; Takahashi N; Node K
    Circ J; 2020 Jul; 84(8):1254-1260. PubMed ID: 32612018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Ullal AJ; Kaiser DW; Fan J; Schmitt SK; Than CT; Winkelmayer WC; Heidenreich PA; Piccini JP; Perez MV; Wang PJ; Turakhia MP
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):39-48. PubMed ID: 27782345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation.
    Ng CY; Liu T; Shehata M; Stevens S; Chugh SS; Wang X
    Am J Cardiol; 2011 Jul; 108(1):47-51. PubMed ID: 21529734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The addition of renal sympathetic denervation to pulmonary vein isolation reduces recurrence of paroxysmal atrial fibrillation in chronic kidney disease patients.
    Kiuchi MG; Chen S; E Silva GR; Rodrigues Paz LM; Kiuchi T; de Paula Filho AG; Lima Souto GL
    J Interv Card Electrophysiol; 2017 Mar; 48(2):215-222. PubMed ID: 27704317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Providencia R; Elliott P; Patel K; McCready J; Babu G; Srinivasan N; Bronis K; Papageorgiou N; Chow A; Rowland E; Lowe M; Segal OR; Lambiase PD
    Heart; 2016 Oct; 102(19):1533-43. PubMed ID: 27234160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
    Schreiber D; Rostock T; Fröhlich M; Sultan A; Servatius H; Hoffmann BA; Lüker J; Berner I; Schäffer B; Wegscheider K; Lezius S; Willems S; Steven D
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):308-17. PubMed ID: 25744570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericardial fat volume is associated with clinical recurrence after catheter ablation for persistent atrial fibrillation, but not paroxysmal atrial fibrillation: an analysis of over 600-patients.
    Kim TH; Park J; Park JK; Uhm JS; Joung B; Lee MH; Pak HN
    Int J Cardiol; 2014 Oct; 176(3):841-6. PubMed ID: 25176630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary vein isolation combined with spironolactone or renal sympathetic denervation in patients with chronic kidney disease, uncontrolled hypertension, paroxysmal atrial fibrillation, and a pacemaker.
    Kiuchi MG; Chen S; Hoye NA; Pürerfellner H
    J Interv Card Electrophysiol; 2018 Jan; 51(1):51-59. PubMed ID: 29264729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial.
    Andrade JG; Khairy P; Macle L; Packer DL; Lehmann JW; Holcomb RG; Ruskin JN; Dubuc M
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):69-75. PubMed ID: 24446022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Atrial Appendage Volume Predicts Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation: A Meta-Analysis.
    Liu Z; Mei X; Jiang H; Cui Y; Yin W; Wang K; Chen T; Zhou Y
    Arq Bras Cardiol; 2023 Mar; 120(3):e20220471. PubMed ID: 36946857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and risks of additional ablation of complex fractionated atrial electrograms for patients with atrial fibrillation: a systematic review and meta-analysis.
    Wu SH; Jiang WF; Gu J; Zhao L; Wang YL; Liu YG; Zhou L; Gu JN; Xu K; Liu X
    Int J Cardiol; 2013 Oct; 169(1):35-43. PubMed ID: 24083885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Relevance of Left Atrial Strain to Predict Recurrence of Atrial Fibrillation after Catheter Ablation: A Meta-Analysis.
    Ma XX; Boldt LH; Zhang YL; Zhu MR; Hu B; Parwani A; Belyavskiy E; Radha Krishnan AK; Krisper M; Köhncke C; Osmanoglou E; Kropf M; Lacour P; Blaschke F; Edelmann F; Tschöpe C; Haverkamp W; Pieske-Kraigher E; Pieske B; Morris DA
    Echocardiography; 2016 May; 33(5):724-33. PubMed ID: 26857344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.